WATSON 802 (Meclizine hydrochloride 12.5 mg)

Pill imprint WATSON 802 has been identified as Meclizine hydrochloride 12.5 mg.

Meclizine is used in the treatment of vertigo; motion sickness; nausea/vomiting and belongs to the drug class anticholinergic antiemetics. There is no proven risk in humans during pregnancy. Meclizine 12.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 802

Meclizine hydrochloride
Imprint:
WATSON 802
Strength:
12.5 mg
Color:
Blue & White
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
Anticholinergic antiemetics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-0802
Inactive Ingredients:
silicon dioxide colloidal
corn starch
FD&C Blue No. 1 Lake
lactose monohydrate
microcrystalline cellulose
povidone
sodium starch glycolate
stearic acid

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)